doi: 10.1016/0960-8966(94)90090-6.
The natural history of type I (severe) spinal muscular atrophy
Affiliations
- PMID: 7881295
- DOI: 10.1016/0960-8966(94)90090-6
Item in Clipboard
The natural history of type I (severe) spinal muscular atrophy
Neuromuscul Disord.
1994 Sep-Nov.
Abstract
The clinical features of 36 patients who satisfied the diagnostic criteria for type I (severe) spinal muscular atrophy (Werdnig-Hoffmann disease) are reported. Survival data for both the whole cohort and for groups within the cohort subdivided on the age of onset are presented. These data suggest that the patients with onset at birth or within the first 2 months of life have a more uniformly poor prognosis with earlier death. This is of potential importance in any therapeutic trials in the future whose outcome may be based on length of survival.
Similar articles
-
Early infantile form of spinal muscular atrophy (Werdnig-Hoffmann disease) with prolonged survival.Folia Neuropathol. 2002;40(1):19-26. Folia Neuropathol. 2002. PMID: 12121035 Review.
-
Spinal muscular atrophy: survival pattern and functional status.Pediatrics. 2004 Nov;114(5):e548-53. doi: 10.1542/peds.2004-0668. Epub 2004 Oct 18. Pediatrics. 2004. PMID: 15492357
-
Spinal muscular atrophy (SMA) type I (Werdnig-Hoffmann disease).Arch Pediatr. 2020 Dec;27(7S):7S15-7S17. doi: 10.1016/S0929-693X(20)30271-2. Arch Pediatr. 2020. PMID: 33357591 Review.
-
The natural history of severe spinal muscular atrophy--further evidence for clinical subtypes.Neuromuscul Disord. 1994 Sep-Nov;4(5-6):527-8. doi: 10.1016/0960-8966(94)90094-9. Neuromuscul Disord. 1994. PMID: 7881299 No abstract available.
-
A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients.J Neurol Sci. 1997 Feb 27;146(1):67-72. doi: 10.1016/s0022-510x(96)00284-5. J Neurol Sci. 1997. PMID: 9077498 Clinical Trial.
Cited by
-
Survival analysis of spinal muscular atrophy type I.Korean J Pediatr. 2010 Nov;53(11):965-70. doi: 10.3345/kjp.2010.53.11.965. Epub 2010 Nov 30. Korean J Pediatr. 2010. PMID: 21218019 Free PMC article.
-
Drug treatment for spinal muscular atrophy types II and III.Cochrane Database Syst Rev. 2020 Jan 6;1(1):CD006282. doi: 10.1002/14651858.CD006282.pub5. Cochrane Database Syst Rev. 2020. PMID: 32006461 Free PMC article.
-
Eighteen Years with Spinal Muscular Atrophy (SMA) Type 1.Tanaffos. 2013;12(1):70-3. Tanaffos. 2013. PMID: 25191452 Free PMC article. No abstract available.
-
Current and emerging treatment options for spinal muscular atrophy.Degener Neurol Neuromuscul Dis. 2015 Jul 17;5:75-81. doi: 10.2147/DNND.S48420. eCollection 2015. Degener Neurol Neuromuscul Dis. 2015. PMID: 32669914 Free PMC article. Review.
-
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.J Neuromuscul Dis. 2018;5(2):145-158. doi: 10.3233/JND-180304. J Neuromuscul Dis. 2018. PMID: 29614695 Free PMC article.